Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study

被引:0
|
作者
Lavarone, Massimo [1 ]
Invernizzi, Federica [1 ]
Czauderna, Carolin [2 ]
Sanduzzi Zamparelli, Marco [3 ]
Bhoori, Sherrie [4 ]
Amaddeo, Giuliana [5 ]
Manini, Matteo Angelo [6 ]
Fraile, Miguel [7 ]
Margarita Anders, Maria [8 ]
Pinter, Matthias [9 ]
Blanco Rodriguez, Maria Jose [10 ]
Romero, Mario [11 ]
Gabriel Alejandro, Aballay Soteras [12 ]
Pinero, Federico [13 ]
Villadsen, Gerda Elisabeth [14 ]
Weinmann, Arndt [2 ]
Crespo, Gonzalo [15 ]
Mazzaferro, Vincenzo [16 ,17 ]
Regnault, Helene [5 ]
De Giorgio, Massimo [6 ]
Gonzalez Dieguez, Maria Luisa [7 ]
Donato, Maria Francesca [1 ]
Varela, Maria [7 ]
Marcus, Worns [2 ]
Bruix, Jordi [3 ]
Lampertico, Pietro [1 ]
Reig, Maria [3 ]
机构
[1] Univ Milan, Div Gastroenterol & Hepatol, CRCAM & A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Milan, Italy
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany
[3] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, IDIBAPS,Liver Unit,CIBERehd, Barcelona, Spain
[4] Fdn IRCCS Ist Nazl Tumori, GI Surg & Liver Trasplantat Unit, Milan, Italy
[5] Hop Henri Mondor, INSERM, U955, Serv Hepatol,Equipe 18,Virus Immunite Canc, Creteil, France
[6] Azienda Socio Sanitaria Terr ASST Papa Giovanni X, Gastroenterol Hepatol & Transplant Unit, Dept Specialty & Transplant Med, Bergamo, Italy
[7] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain
[8] Hosp Aleman, Unidad Hepatol & Trasplante Hepat, Buenos Aires, DF, Argentina
[9] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[10] Hosp Jerez, Jerez de la Frontera, Spain
[11] Gregorio Maranon Hosp, Liver Dept, Madrid, Spain
[12] Sanatorio Trinidad Mitre, Caba, Argentina
[13] Hosp Univ Austral, Sch Med, Buenos Aires, DF, Argentina
[14] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus C, Denmark
[15] Univ Barcelona, Liver Transplant Unit, Liver Unit, Hosp Clin,IDIBAPS,CIBERehd, Barcelona, Spain
[16] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[17] Univ Milan, GI Surg & Liver Trasplantat Unit, Milan, Italy
关键词
D O I
10.1016/S0618-8278(19)31209-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-473
引用
收藏
页码:E606 / E607
页数:2
相关论文
共 50 条
  • [31] Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study
    Tunbekici, Salih
    Yuksel, Haydar cagatay
    Acar, Caner
    Sahin, Goekhan
    Orman, Seval
    Majidova, Nargiz
    Coskun, Alper
    Seyyar, Mustafa
    Dilek, Mehmet siddik
    Kara, Mahmut
    Disli, Ahmet Kursat
    Demir, Teyfik
    Kolkiran, Nagihan
    Sahbazlar, Mustafa
    Demirciler, Erkut
    Kus, Fatih
    Aytac, Ali
    Menekse, Serkan
    Yucel, Hakan
    Biter, Sedat
    Koseci, Tolga
    Unsal, Ahmet
    Ozveren, Ahmet
    Sevinc, Alper
    Goker, Erdem
    Gursoy, Pinar
    CANCERS, 2025, 17 (01)
  • [32] Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study
    Ramos, F. Javier Melgosa
    Gonzalez-Delgado, Victor
    Motilla, Jose Maria Sanchez
    Marta, Galarreta Pascual
    Mateu Puchades, Almudena
    Sergio, Santos Alarcon
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e361 - e364
  • [33] Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy
    Scribano, Maria Lia
    Aratari, Annalisa
    Neri, Benedetto
    Bezzio, Cristina
    Balestrieri, Paola
    Baccolini, Valentina
    Falasco, Giuliano
    Camastra, Caterina
    Pantanella, Paolo
    Monterubbianesi, Rita
    Tullio, Alessandro
    Saibeni, Simone
    Papi, Claudio
    Biancone, Livia
    Cosintino, Rocco
    Faggiani, Roberto
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [34] Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
    Zhang, Xia
    Cai, Lirong
    Fang, Jian
    Chen, Fengsui
    Pan, Fan
    Zhang, Kun
    Huang, Qian
    Huang, Yuju
    Li, Dongliang
    Lv, Lizhi
    Chen, Man
    Yan, Ruiying
    Lai, Yanhua
    Peng, Yonghai
    Wu, Zhixian
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [35] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival
    Mazza, S.
    Invernizzi, F.
    Iavarone, M.
    Zavaglia, C.
    Maggi, U.
    Cesarini, L.
    Antonelli, B.
    Airoldi, A.
    Manini, M. A.
    Sangiovanni, A.
    Rossi, G.
    Donato, M. F.
    Belli, L. S.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E35 - E35
  • [36] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
    Invernizzi, F.
    Iavarone, M.
    Donato, M. F.
    Sangiovanni, A.
    Monico, S.
    Manini, M. A.
    Maggi, U.
    Antonelli, B.
    Dondossola, D.
    Rossi, G.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 49 - 49
  • [37] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
    Invernizzi, Federica
    Iavarone, Massimo
    Zavaglia, Claudio
    Mazza, Stefano
    Maggi, Umberto
    Cesarini, Lucia
    Antonelli, Barbara
    Airoldi, Aldo
    Manini, Matteo Angelo
    Sangiovanni, Angelo
    Rossi, Giorgio
    Donato, Maria Francesca
    Belli, Luca Saverio
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E560 - E561
  • [38] Sofosbuvir as the backbone of treatment for HCV after liver transplantation: a real-life multicenter experience
    Satoskar, Rohit
    Ahn, Joseph
    Te, Helen S.
    Deising, Adam
    Aronsohn, Andrew
    Robertazzi, Suzanne
    Schiano, Thomas D.
    HEPATOLOGY, 2014, 60 : 537A - 537A
  • [39] Real-life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
    Baselga Torres, Eulalia
    Ivars, Marta
    Prat, Carolina
    Vicente, Asuncion
    Rodriguez, Marta Feito
    Maseda Pedrero, Rocio
    Martin Santiago, Ana
    Giacaman, Aniza
    Fernandez, Antonio Torrelo
    Noguera-Morel, Lucero
    Betlloch Mas, Isabel
    de Berbegal Gracia, Laura
    Buselli, Montserrat Evole
    Pozuelo Ruiz, Monica
    Bernabeu Wittel, Jose
    Garcia, Maria T. Monserrat
    Dominguez, Minia Campos
    Galache Osuna, Cristina
    Jimenez, Jorge Santos-Juanes
    Martinez, Altea Esteve
    Zaragoza Ninet, Violeta
    Casals Andreu, Miquel
    Perez, Sara I. Palencia
    Hernandez, Jose Suarez
    Dorta Alom, Sara
    Feliciano Divasson, Laura
    Batalla Cebey, Ana
    Gutierrez, Manuel Galan
    de Lucas Laguna, Raul
    JEADV CLINICAL PRACTICE, 2025,
  • [40] Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
    Roberta Rudà
    Francesco Bruno
    Alessia Pellerino
    Edoardo Pronello
    Rosa Palmiero
    Luca Bertero
    Stefania Crasto
    Valentina Polo
    Roberta Vitaliani
    Elena Trincia
    Valeria Internò
    Camillo Porta
    Riccardo Soffietti
    Journal of Neuro-Oncology, 2022, 160 : 389 - 402